Analysis of Heart-Rate Variability during Angioedema Attacks in Patients with Hereditary C1-Inhibitor Deficiency.
C1-inhibitor hereditary angioedema
autonomic nervous system
burden of disease
cardiac neural control
heart rate variability
multiday ECG monitoring
quality of life
spectral analysis
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
12 03 2021
12 03 2021
Historique:
received:
10
02
2021
revised:
01
03
2021
accepted:
09
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
24
4
2021
Statut:
epublish
Résumé
C1-inhibitor hereditary angioedema (C1-INH-HAE) is a rare disease characterized by self-limiting edema associated with localized vasodilation due to increased levels of circulating bradykinin. C1-INH-HAE directly influences patients' everyday lives, as attacks are unpredictable in frequency, severity, and the involved anatomical site. The autonomic nervous system could be involved in remission. The cardiac autonomic profile has not yet been evaluated during the attack or prodromal phases. In this study, a multiday continuous electrocardiogram was obtained in four C1-INH-HAE patients until attack occurrence. Power spectral heart rate variability (HRV) indices were computed over the 4 h preceding the attack and during the first 4 h of the attack in three patients. Increased vagal modulation of the sinus node was detected in the prodromal phase. This finding may reflect localized vasodilation mediated by the release of bradykinin. HRV analysis may furnish early markers of an impending angioedema attack, thereby helping to identify patients at higher risk of attack recurrence. In this perspective, it could assist in the timing, titration, and optimization of prophylactic therapy, and thus improve patients' quality of life.
Identifiants
pubmed: 33809031
pii: ijerph18062900
doi: 10.3390/ijerph18062900
pmc: PMC8002127
pii:
doi:
Substances chimiques
Bradykinin
S8TIM42R2W
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Ann N Y Acad Sci. 2001 Jun;940:299-306
pubmed: 11458687
Ann Noninvasive Electrocardiol. 2008 Apr;13(2):191-207
pubmed: 18426445
Allergy Asthma Proc. 2020 Nov 1;41(Suppl 1):S08-S13
pubmed: 33109318
Orphanet J Rare Dis. 2015 Feb 06;10:11
pubmed: 25758562
Pharmacol Rev. 2005 Mar;57(1):27-77
pubmed: 15734727
Med Biol Eng Comput. 1998 Jan;36(1):35-42
pubmed: 9614746
Ann Allergy Asthma Immunol. 2010 Apr;104(4):314-20
pubmed: 20408341
Can J Physiol Pharmacol. 2002 Apr;80(4):249-57
pubmed: 12025957
Circ Res. 1986 Aug;59(2):178-93
pubmed: 2874900
Eur Heart J. 1996 Mar;17(3):354-81
pubmed: 8737210
Lancet. 2012 Feb 4;379(9814):474-81
pubmed: 22305226
Am J Obstet Gynecol. 2008 Nov;199(5):484.e1-4
pubmed: 18554570
Allergy. 2014 May;69(5):602-16
pubmed: 24673465
Allergy Asthma Proc. 2010 Sep-Oct;31(5):407-14
pubmed: 20929608
Front Med (Lausanne). 2018 Apr 20;5:111
pubmed: 29732372
J Intern Med. 2019 Sep;286(3):240-258
pubmed: 30565762
Am J Physiol. 1985 Jan;248(1 Pt 2):H151-3
pubmed: 3970172
Am J Physiol. 1997 Aug;273(2 Pt 2):R637-45
pubmed: 9277549
Neuroscience. 2017 Dec 4;365:23-32
pubmed: 28951324
J Clin Endocrinol Metab. 2002 Sep;87(9):4245-51
pubmed: 12213879
PLoS One. 2014 Jul 18;9(7):e102342
pubmed: 25036185
Acta Derm Venereol. 2015 Jul;95(6):706-10
pubmed: 25394853
Br J Pharmacol. 2004 May;142(2):285-96
pubmed: 15066903
J Allergy Clin Immunol. 1999 Dec;104(6):1321-2
pubmed: 10589018
PLoS One. 2017 Nov 6;12(11):e0187110
pubmed: 29107952
Chaos. 2007 Mar;17(1):015117
pubmed: 17411274
Circ Res. 1969 Jan;24(1):109-21
pubmed: 4303309